Upregulation of antioxidant genes in antimony-resistant Leishmania tropica clinical isolates
Authors:
- 23 April 2025
- journal article
- research article
- Published by Springer Nature in Molecular Biology Reports
- Vol. 52 (1) , 1-13
Abstract
Background Increasing resistance to antimonial drugs has become a significant challenge in effective treatment in endemic regions of leishmaniasis. Antioxidant defense plays a crucial role in antimony resistance by combating antimonial-induced oxidative stress. Accordingly, we investigated the transcript levels of some antioxidant genes in antimony-sensitive and resistant clinical Leishmania tropica isolates. Methods In the current study, 22 Leishmania tropica isolates from ACL patients who presented responsive or unresponsive to antimony were examined. The susceptibility of parasites against SbV and hydrogen peroxide (H2O2) was analyzed. We evaluated the transcript levels of five genes, including cytosolic and mitochondrial tryparedoxin (cTXN, mTXN), cytosolic and mitochondrial tryparedoxin peroxidase (cTXNPx, mTXNPx), and ascorbate peroxidase (APX) in antimony-sensitive and resistant L. tropica clinical isolates. Results The in-vitro susceptibility to SbV in intracellular amastigotes revealed 3.82 times higher IC50 in resistant isolates compared to sensitive ones. The IC50 toward H2O2 in resistant isolates was 1.6 times higher than in sensitive ones, positively correlated with SbV IC50 values. The average transcript expression level of cTXNPx, mTXNPx, cTXN, and APX genes significantly increased in resistant isolates by 2.51, 1.69, 2.41, and 2.12-fold compared to sensitive ones. The highest correlation coefficient between the gene expression and SbV IC50 values belonged to the cTXNPx, cTXN, APX, mTXN, and mTXNPx genes, respectively. The average transcript expression level of cytosolic TXN and TXNPx in resistant L. tropica isolates was higher than its mitochondrial counterpart. Conclusions The data presented here revealed a phenotypic heterogeneity in antioxidant gene expression among L. tropica clinical isolates. Overall, the upregulation of genes involved in antioxidant defense could probably contribute to natural antimony resistance in L. tropica clinical isolates.Keywords
Funding Information
- Pasteur Institute of Iran, Iran, Islamic Republic Of (482)
This publication has 53 references indexed in Scilit:
- Cutaneous Leishmaniasis: A 2022 Updated Narrative Review into Diagnosis and Management DevelopmentsAmerican Journal of Clinical Dermatology, 2022
- Downregulation of GJB2 and SLC26A4 genes induced by noise exposure is associated with cochlear damageMolecular Biology Reports, 2022
- Involvement of tryparedoxin peroxidase (TryP) and trypanothione reductase (TryR) in antimony unresponsive of Leishmania tropica clinical isolates of IranActa Tropica, 2022
- Genetic diversity of Leishmania tropica: Unexpectedly complex distribution patternActa Tropica, 2021
- Differentially modulated proteins associated with Leishmaniasis—a systematic review of in-vivo and in-vitro studiesMolecular Biology Reports, 2020
- Gene expression analysis of antimony resistance in Leishmania tropica using quantitative real-time PCR focused on genes involved in trypanothione metabolism and drug transportArchives of Dermatological Research, 2018
- Phosphoproteomic analysis of wild‐type and antimony‐resistant Leishmania braziliensis lines by 2D‐DIGE technologyProteomics, 2015
- Biomarkers of antimony resistance: need for expression analysis of multiple genes to distinguish resistance phenotype in clinical isolates of Leishmania donovaniParasitology Research, 2012
- The thiol‐based redox networks of pathogens: Unexploited targets in the search for new drugsBioFactors, 2006
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001